Hadron therapy is an advanced cancer treatment that employs beams of protons or carbon ions to deliver dose with sub-millimetre accuracy. The extreme precision of this approach, however, means that treatment can be compromised if the range of the charged particles differs from the treatment plan. As such, range verification techniques are under investigation, with PET imaging of positron emitters generated by the treatment beam already in clinical use. {read more here}

There is new evidence that the rate at which mesothelioma tumors metabolize glucose could provide significant prognostic information for mesothelioma patients and their doctors. {read more here}

A new study revealed that imaging techniques such as positron-emission tomography (PET)/computed tomography (CT) can detect laryngeal inflammation in sarcoidosis patients, allowing the diagnosis of laryngeal sarcoidosis. {read more here}

Using positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer, researchers were able to assess patient response to treatment and adjust their therapy, leading to an improved rate of pathologic complete response prior to surgery.  {read more here}